ARVINAS, INC.
For the period ended Jun 30, 2026. Filed Aug 4, 2026.
View on SEC.govAbout this filing
A company's report for each of its first three quarters. The financial statements are not audited. It shows how the business has moved since the last annual report, and what management says changed.
Jun 30, 2026 · Filed Aug 4, 2026
ARVN$6.92+2.4%Stored close · as of Nov 10, 2026
Extracted filing text, with the paragraph anchors used by the comparison.
See the whole filing, with its images and exhibitsContents
Condensed Consolidated Statements of Cash Flows
Condensed Consolidated Statements of Cash Flows (unaudited)
| For the Six Months EndedJune 30, | ||
|---|---|---|
| (dollars in millions) | 2026 | 2025 |
| Cash flows from operating activities: | ||
| Net income | $111.8 | $21.7 |
| Adjustments to reconcile net income to net cash used in operating activities: | ||
| Depreciation and amortization | 1.4 | 1.5 |
| Net accretion of bond discounts/premiums | (3.2) | (7.3) |
| Amortization of right-of-use assets | 0.9 | 1.2 |
| Amortization of collaboration contract asset | 3.5 | 3.7 |
| Stock-based compensation | 18.0 | 25.3 |
| Changes in operating assets and liabilities: | ||
| Accounts receivable | (49.3) | 5.2 |
| Other receivables | 1.4 | (2.6) |
| Prepaid expenses and other assets | (4.6) | (3.1) |
| Contract assets | (26.8) | — |
| Accounts payable and accrued liabilities | (16.9) | (17.6) |
| Operating lease liability | (0.9) | (1.0) |
| Deferred revenue | (205.5) | (211.3) |
| Collaboration liability | 52.7 | — |
| Net cash used in operating activities | (117.5) | (184.3) |
| Cash flows from investing activities: | ||
| Purchases of marketable securities | (239.3) | (237.6) |
| Maturities of marketable securities | 280.5 | 437.5 |
| Sales of marketable securities | 28.9 | — |
| Purchases of property, equipment and leasehold improvements | (1.5) | (1.6) |
| Net cash provided by investing activities | 68.6 | 198.3 |
| Cash flows from financing activities: | ||
| Repayments of long-term debt | (0.2) | (0.1) |
| Proceeds from exercise of stock options and issuance of ESPP shares | 0.5 | 0.5 |
| Net cash provided by financing activities | 0.3 | 0.4 |
| Net (decrease) increase in cash and cash equivalents | (48.6) | 14.4 |
| Cash and cash equivalents, beginning of the period | 142.9 | 100.5 |
| Cash and cash equivalents, end of the period | $94.3 | $114.9 |
The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.